`Date filed: March 27, 2018
`
`
`Filed On Behalf Of:
`
`Novartis Pharmaceuticals Corporation
`
`By:
`
`Nicholas N. Kallas
`NKallas@fchs.com
`ZortressAfinitorIPR@fchs.com
`(212) 218-2100
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`
`
`Case IPR2018-00507
`Patent 8,410,131
`
`
`
`
`WAIVER OF PATENT OWNER’S PRELIMINARY RESPONSE
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.107(b), Patent Owner Novartis Pharmaceuticals
`
`Corporation hereby elects to waive its preliminary response in this Inter Partes
`
`Review No. 2018-00507. As indicated in the Trial Practice Guide, no adverse
`
`inference should be taken by this election. See Office Trial Practice Guide, Fed.
`
`Reg. Vol. 77, No. 157 (2012) at Section II.C. This election shall not constitute a
`
`waiver or admission by Patent Owner with respect to any material set forth in the
`
`/ Nicholas N. Kallas /
`Nicholas N. Kallas
`Registration No. 31,530
`Lead Counsel for Patent Owner
`FITZPATRICK, CELLA, HARPER
`& SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`Petition.
`
`
`
`Respectfully submitted,
`
`
`Dated: March 27, 2018
`
`
`
`
`
`1
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I certify that a copy of Waiver Of Patent Owner’s Preliminary Response was
`
`served on March 27, 2018 by causing it to be sent by email to counsel for
`
`Petitioner at the following email addresses:
`
`Keith A. Zullow (kzullow@goodwinprocter.com)
`
`Marta E. Delsignore (mdelsignore@goodwinprocter.com)
`
`
`
`Dated: March 27, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/ Nicholas N. Kallas /
`Nicholas N. Kallas
`Registration No. 31,530
`FITZPATRICK, CELLA, HARPER
`& SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`
`
`
`
`
`
`2
`
`